← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

$0

Shares

53,960

Price

$0

Filed

Feb 3

Insider

Name

Kaseta Michael

Title

CIK

0001724346

Roles

Director

Transaction Details

Transaction Date

2026-01-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

53,960

Footnotes

The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.

Filing Info

Accession No.

0001193125-26-034631

Form Type

4

Issuer CIK

0000818033

Kaseta Michael's History

Date Ticker Type Value
2026-04-15 LQDA $363K
2026-04-15 LQDA M $243K
2026-04-15 LQDA $3.5M
2026-04-15 LQDA $1.7M
2026-04-15 LQDA M $0
2026-04-14 LQDA M $8K
2026-04-14 LQDA $120K
2026-04-14 LQDA M $0
2026-04-13 LQDA $727K
2026-04-10 LQDA M $66K

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Dissanaike Sharmila 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30